CN110462025B - 增强干细胞存活和增殖的培养基和方法 - Google Patents

增强干细胞存活和增殖的培养基和方法 Download PDF

Info

Publication number
CN110462025B
CN110462025B CN201880019192.7A CN201880019192A CN110462025B CN 110462025 B CN110462025 B CN 110462025B CN 201880019192 A CN201880019192 A CN 201880019192A CN 110462025 B CN110462025 B CN 110462025B
Authority
CN
China
Prior art keywords
acid
stem cells
lipid
cells
culture medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201880019192.7A
Other languages
English (en)
Chinese (zh)
Other versions
CN110462025A (zh
Inventor
A·赫斯特
M·卡德尔
W·常
M·希亚特
E·杰维斯
A·亨特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stemcell Technologies Canada Inc
Original Assignee
Stemcell Technologies Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=62907538&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN110462025(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stemcell Technologies Canada Inc filed Critical Stemcell Technologies Canada Inc
Publication of CN110462025A publication Critical patent/CN110462025A/zh
Application granted granted Critical
Publication of CN110462025B publication Critical patent/CN110462025B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Transplantation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN201880019192.7A 2017-01-23 2018-01-23 增强干细胞存活和增殖的培养基和方法 Active CN110462025B (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201762449413P 2017-01-23 2017-01-23
US62/449,413 2017-01-23
US201762518776P 2017-06-13 2017-06-13
US62/518,776 2017-06-13
US201762608875P 2017-12-21 2017-12-21
US62/608,875 2017-12-21
PCT/CA2018/050076 WO2018132926A1 (en) 2017-01-23 2018-01-23 Media and methods for enhancing the survival and proliferation of stem cells

Publications (2)

Publication Number Publication Date
CN110462025A CN110462025A (zh) 2019-11-15
CN110462025B true CN110462025B (zh) 2023-11-21

Family

ID=62907538

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880019192.7A Active CN110462025B (zh) 2017-01-23 2018-01-23 增强干细胞存活和增殖的培养基和方法

Country Status (9)

Country Link
US (2) US11697796B2 (enExample)
EP (2) EP4361256A3 (enExample)
JP (1) JP7049347B2 (enExample)
CN (1) CN110462025B (enExample)
AU (1) AU2018209127B2 (enExample)
CA (1) CA3051141C (enExample)
IL (1) IL268194B (enExample)
SG (1) SG11201906731XA (enExample)
WO (1) WO2018132926A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3051141C (en) 2017-01-23 2021-06-22 Stemcell Technologies Canada Inc. Media and methods for enhancing the survival and proliferation of stem cells
CN111808797A (zh) * 2020-07-28 2020-10-23 湖南赛诺生物科技股份有限公司 Necrostatin-1的应用及促进新生猪胰岛细胞成熟的制剂
JP2022032793A (ja) * 2020-08-14 2022-02-25 アルブキュラ コーポレーション アルブミン組成物並びにそれを製造及び使用する方法
IL300809A (en) 2020-09-02 2023-04-01 Yztherapeutic Performance Ltd Cellular preparation for the treatment of diseases and method of use
WO2022114724A1 (ko) * 2020-11-27 2022-06-02 (주)엑셀세라퓨틱스 고효율 및 고순도 엑소좀 생산용 배지 조성물
WO2022173058A1 (ja) * 2021-02-15 2022-08-18 凸版印刷株式会社 三次元組織体の製造方法及び脂肪由来幹細胞の分化促進方法
CN116121186A (zh) * 2023-01-03 2023-05-16 内蒙古奥普赛生物科技有限公司 一种利用棕榈油酸培养脂肪间充质干细胞的方法
WO2024216399A1 (en) * 2023-04-20 2024-10-24 Stemcell Technologies Canada Inc. Methods for large scale expansion of pluripotent stem cells (pscs)
CN116814532B (zh) * 2023-07-10 2025-02-11 上海迈邦生物科技有限公司 一种用于哺乳动物细胞培养基的脂类复合物及其制备方法与应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101052712A (zh) * 2004-09-08 2007-10-10 威斯康星校友研究基金会 培养人胚胎干细胞
CN101182464A (zh) * 2006-05-16 2008-05-21 贝克顿·迪金森公司 用于细胞培养的经细胞外基质包被的表面
JP2009542247A (ja) * 2006-07-12 2009-12-03 ユニヴァーシティー オヴ シェフィールド 細胞増殖培地
JP2012175962A (ja) * 2011-01-31 2012-09-13 National Institute Of Biomedical Innovation ヒト多能性幹細胞の培養方法
CN105283541A (zh) * 2013-05-30 2016-01-27 味之素株式会社 干细胞培养用培养基
CA2981277A1 (en) * 2015-03-30 2016-10-06 Ajinomoto Co., Inc. Human serum albumin-containing culture medium for growth of neural stem cells

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0986635A4 (en) 1997-01-10 2001-11-07 Life Technologies Inc SERUM SUBSTITUTE FOR EMBRYONIC STEM CELLS
US9074176B2 (en) * 2006-01-13 2015-07-07 Two Cells Co., Ltd. Culture medium additive for use in serum-free culturing of animal cell, kit and use thereof
ES2360782B1 (es) 2009-07-28 2012-03-12 Grifols, S.A. Medios para cultivo de células de mamíferos que comprenden sobrenadante de etapas del fraccionamiento de Cohn y uso de los mismos.
FI20096288A0 (fi) * 2009-12-04 2009-12-04 Kristiina Rajala Formulations and methods for culturing stem cells
WO2011085072A2 (en) 2010-01-06 2011-07-14 Ervin Industries, Inc. Frangible, ceramic-metal composite objects and methods of making the same
US8497124B2 (en) * 2011-12-05 2013-07-30 Factor Bioscience Inc. Methods and products for reprogramming cells to a less differentiated state
RU2018128383A (ru) 2012-03-07 2019-03-14 Янссен Байотек, Инк. Среда определенного состава для размножения и обновления плюрипотентных стволовых клеток
JP2016521971A (ja) * 2013-04-23 2016-07-28 イェダ リサーチ アンド ディベロップメント カンパニー リミテッド 単離ナイーブ型多能性幹細胞およびそれを発生させる方法関連出願本出願は、米国特許法１１９条第（ｅ）項に基づき、２０１４年１月２９日出願の米国特許仮出願第６１／９３２，９３５号、２０１３年９月１７日出願の米国特許仮出願第６１／８７８，７６９号、および２０１３年４月２３日出願の米国特許仮出願第６１／８１４，９２０号の優先権を主張する。また、本出願は、同時に提出された同出願人による同時係属出願である、ＹａｑｕｂＨＡＮＮＡ、ＮｏａＮＯＶＥＲＳＨＴＥＲＮ、およびＹｏａｃｈＲＡＩＳによる米国特許出願（発明の名称「単離ナイーブ型多能性幹細胞およびそれを発生させる方法（ＩＳＯＬＡＴＥＤＮＡＩＶＥＰＬＵＲＩＰＯＴＥＮＴＳＴＥＭＣＥＬＬＳＡＮＤＭＥＴＨＯＤＳＯＦＧＥＮＥＲＡＴＩＮＧＳＡＭＥ）」）（代理人事件記録簿第５８８７０号）にも関する。上記出願の内容はその全体を参考として本明細書に組み込む。
WO2015042356A1 (en) * 2013-09-19 2015-03-26 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Chemically defined culture medium for stem cell maintenance and differentiation
CA3051141C (en) 2017-01-23 2021-06-22 Stemcell Technologies Canada Inc. Media and methods for enhancing the survival and proliferation of stem cells

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101052712A (zh) * 2004-09-08 2007-10-10 威斯康星校友研究基金会 培养人胚胎干细胞
CN101182464A (zh) * 2006-05-16 2008-05-21 贝克顿·迪金森公司 用于细胞培养的经细胞外基质包被的表面
JP2009542247A (ja) * 2006-07-12 2009-12-03 ユニヴァーシティー オヴ シェフィールド 細胞増殖培地
JP2012175962A (ja) * 2011-01-31 2012-09-13 National Institute Of Biomedical Innovation ヒト多能性幹細胞の培養方法
CN105283541A (zh) * 2013-05-30 2016-01-27 味之素株式会社 干细胞培养用培养基
CA2981277A1 (en) * 2015-03-30 2016-10-06 Ajinomoto Co., Inc. Human serum albumin-containing culture medium for growth of neural stem cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Effect of ROCK inhibitor Y-27632 on normal and variant human embryonic stem cells (hESCs) in vitro: its benefits in hESC expansion;Kalamegam Gauthaman et al.;《Stem Cell Rev Rep》;20100331;第6卷(第1期);摘要 *

Also Published As

Publication number Publication date
US20230250392A1 (en) 2023-08-10
US20200017825A1 (en) 2020-01-16
SG11201906731XA (en) 2019-08-27
EP4361256A2 (en) 2024-05-01
IL268194A (en) 2019-09-26
AU2018209127A1 (en) 2019-08-08
EP4361256A3 (en) 2024-07-31
CA3051141A1 (en) 2018-07-26
EP3571290A4 (en) 2020-10-28
JP2020505038A (ja) 2020-02-20
IL268194B (en) 2022-05-01
CN110462025A (zh) 2019-11-15
EP3571290B1 (en) 2024-04-10
US11697796B2 (en) 2023-07-11
EP3571290A1 (en) 2019-11-27
WO2018132926A1 (en) 2018-07-26
AU2018209127B2 (en) 2021-10-21
JP7049347B2 (ja) 2022-04-06
CA3051141C (en) 2021-06-22

Similar Documents

Publication Publication Date Title
CN110462025B (zh) 增强干细胞存活和增殖的培养基和方法
CN103589683B (zh) 一种脐带间充质干细胞的分离方法和培养方法
CN1871343B (zh) 从脂肪组织制备干细胞的方法和系统
US9339520B2 (en) Methods and compositions for treatment of bone defects with placental cell populations
KR102862875B1 (ko) 배양 배지
EP3074505B1 (en) Serum-free medium
JP2008271971A (ja) 脂肪由来前駆細胞の細胞分化
CN112608891A (zh) 一种间充质干细胞无血清培养基及其应用
WO2021254296A1 (zh) 一种生物活性物质组合物、包含所述组合物的无血清培养基及其用途
Sardesai et al. Avoidance of maternal cell contamination and overgrowth in isolating fetal chorionic villi mesenchymal stem cells from human term placenta
CN113692282A (zh) 一种生物活性物质组合物、包含所述组合物的无血清培养基及其用途
EP3963050B1 (en) Preparation of human allogeneic liver-derived progenitor cells
Araujo et al. Long-term in vitro culture of bovine preantral follicles: effect of base medium and medium replacement methods
US20220220445A1 (en) Preparation of human allogeneic liver-derived progenitor cells
HK40110808A (en) Media and methods for enhancing the survival and proliferation of stem cells
HK40017314A (en) Media and methods for enhancing the survival and proliferation of stem cells
HK40017314B (en) Media and methods for enhancing the survival and proliferation of stem cells
JP2024529729A (ja) 加齢関連疾患および神経変性疾患の予防および処置におけるｉＰＳＣ由来免疫細胞
Korovina The use of bovine multipotent mesenchymal stem cells isolated from bone marrow and adipose tissue as sources to obtain muscle cells in vitro
JP7758411B1 (ja) 間葉系幹細胞培養物の製造方法
Dehdilani et al. Enhanced Cultivation of Chicken Primordial Germ Cells: A Comparison of Enriched and Defined Media
WO2025253985A1 (ja) 間葉系幹細胞培養物の製造方法
TWI403582B (zh) 促使神經幹細胞增生及／或分化的培養基
HK40068803B (en) Preparation of human allogeneic liver-derived progenitor cells
HK40068803A (en) Preparation of human allogeneic liver-derived progenitor cells

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TG01 Patent term adjustment
TG01 Patent term adjustment